InMode to Present at Canaccord Genuity MedTech & Diagnostics Forum

YOQNEAM, Israel, Nov. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Canaccord Genuity MedTech & Diagnostics Forum at the Westin Grand Central, New York City on November 21^st at 11:30 am EST.

Mr. Mizrahy will be available for one-on-one meetings during the conference. To schedule a meeting please contact your Canaccord salesperson or Miri Segal at [email protected].

A live webcast of the presentation will be available to the public at: http://wsw.com/webcast/canaccord37/inmd/. The webcast will be archived for 90 days following the live presentation.

About Canaccord Genuity MedTech & Diagnostics Forum

Canaccord's MedTech Conference will profile public and private Med-Tech and Diagnostic companies in Cardiovascular, Diabetes, ENT, Respiratory, Wound Care, Women's Healthcare, Ophthalmology, Aesthetics, Obesity, Robotics & Imaging, Diagnostics, Liquid Biopsies, Precision Medicine and Next Generation Sequencing. 

About InMode 

InMode is a leading global provider of innovative medical technologies.  InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology.  InMode strives to enable new emerging surgical procedures as well as improve existing treatments.  InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.  For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal
MS-IR LLC
Phone: (917) 607-8654
Email: [email protected]

SOURCE InMode

Related Links

http://www.inmodemd.com